Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer
Phase 3 Terminated
55 enrolled
TOGAR
Phase 2 Terminated
3 enrolled
A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors
Phase 1 Terminated
157 enrolled
Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the Extremities
Phase 1 Terminated
9 enrolled
INTEGRAL
Phase 2 Terminated
8 enrolled 10 charts
Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus.
Phase 2 Terminated
71 enrolled
OTT15-04
Phase 4 Terminated
2 enrolled 4 charts
ELEVATE HNSCC
Phase 2 Terminated
193 enrolled 27 charts
Docetaxel With or Without Bintrafusp Alfa for the Treatment of Advanced Non-small Cell Lung Cancer
Phase 2 Terminated
10 enrolled 17 charts
Phase II Trial of Magrolimab and Cetuximab With Pembrolizumab or Docetaxel for Recurrent/Metastatic Head Neck Squamous Cell Carcinoma
Phase 2 Terminated
4 enrolled 11 charts
Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer
Phase 1 Terminated
4 enrolled
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
Phase 1/2 Terminated
19 enrolled
Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma
Phase 2 Terminated
96 enrolled 17 charts
Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency
Phase 2 Terminated
18 enrolled
GeoMETry-III
Phase 3 Terminated
22 enrolled 22 charts
ELEVATELung&UC
Phase 2 Terminated
106 enrolled 22 charts
RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer
Phase 1 Terminated
15 enrolled
CABPOSTAAT
Phase 2 Terminated
57 enrolled
Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers
Phase 1 Terminated
272 enrolled
FORTITUDE-201
Phase 1 Terminated
74 enrolled 22 charts
A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer
Phase 1/2 Terminated
36 enrolled 26 charts
Acclaim-2
Phase 1/2 Terminated
5 enrolled
LUME-Columbus: Nintedanib Plus Docetaxel in Advanced Non-small Cell Lung Cancer With Translational Research
Phase 3 Terminated
12 enrolled 7 charts
FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer
Phase 2 Terminated
5 enrolled 11 charts
A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid Tumors
Phase 1 Terminated
54 enrolled 42 charts
A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic Malignancies
Phase 1 Terminated
21 enrolled
PECORINO
Phase 2 Terminated
69 enrolled
Study of Docetaxel Combined with Cirmtuzumab in Metastatic Castration Resistant Prostate Cancer
Phase 1 Terminated
6 enrolled
Study to Assess the Effects of GS-3583 in Participants With Advanced Solid Tumors
Phase 1 Terminated
13 enrolled 18 charts
Intraperitoneal Docetaxel in Combination With mFOLFOX6 for Gastric Cancer Patients With Peritoneal Carcinomatosis
Phase 1 Terminated
2 enrolled
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors
Phase 1 Terminated
30 enrolled
Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss
Phase 1 Terminated
123 enrolled
KEYNOTE-921
Phase 3 Terminated
81 enrolled 19 charts
Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC)
Phase 1/2 Terminated
41 enrolled 11 charts
DOP
Phase 1 Terminated
24 enrolled
Compare the Efficacy and the Safety of Taxotere and Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer
Phase 3 Terminated
26 enrolled
A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors
Phase 2 Terminated
86 enrolled
SCT-I10A or Placebo Plus Docetaxel With Previously Treated Squamous Cell Non-small Cell Lung Cancer
Phase 3 Terminated
188 enrolled
BREC
Phase 3 Terminated
382 enrolled 15 charts
A Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1
Phase 1/2 Terminated
18 enrolled 15 charts
Trial of Pevonedistat Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer
Phase 2 Terminated
40 enrolled 13 charts
Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery
Phase 2 Terminated
3 enrolled 6 charts
Trial of Atezolizumab Plus Chemotherapy After Progression on PD-1 or PD-L1 in Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
Phase 2 Terminated
6 enrolled 18 charts
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma
Phase 1/2 Terminated
23 enrolled 15 charts
Neoadjuvant Dose-Dense For Early Her2Neu Positive Breast Cancer
Phase 2 Terminated
7 enrolled 10 charts
CANOPY-2
Phase 3 Terminated
245 enrolled 29 charts
A Study to Evaluate Camrelizumab Combined With Famitinib as Subsequent Therapy in Patients With Advanced NSCLC
Phase 3 Terminated
1 enrolled
Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer
Phase 2 Terminated
11 enrolled 7 charts
DART
Phase 3 Terminated
48 enrolled
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
Phase 2 Terminated
22 enrolled 5 charts